Skip to Content

Research & Funding

Past Other NCI & NIH InitiativesRSS

This page lists past other NCI and NIH cancer imaging initiatives, including grant mechanisms.

Requests for Application (RFA) are usually announced with special application dates; there is no possibility for applying after that date. Program Announcements (PA, PAR) may be open for a set period of time, such as 3 years or less; applications submitted in response to Program Announcements may be due on the standard dates (February 1, June1, and October 1) or may have special dates for receipt of applications. Please pay attention to these dates. Contact a CIP staff member if you have questions.

  • PAR-13-137: Bioengineering Research Grants (R01)

    • Release Date: June 20, 2013
    • Application Receipt Date: Standard dates apply: see http://grants.nih.gov/grants/funding/submissionschedule.htm
    • Expiration Date: Standard dates apply: see http://grants.nih.gov/grants/funding/submissionschedule.htm
  • PA-12-284: Exploratory / Developmental Bioengineering Research Grants (R21)

    • Release Date: June 20, 2013
    • Application Receipt Date: Standard dates apply: see http://grants.nih.gov/grants/funding/submissionschedule.htm
    • Expiration Date: Standard dates apply: see http://grants.nih.gov/grants/funding/submissionschedule.htm
  • PAR-13-189: Imaging and Biomarkers for Early Cancer Detection (R01)

    • Release Date: May 14, 2013
    • Application Receipt Date: July 10, 2013, December 11, 2013, July 10, 2014, December 11, 2014, July 10, 2015, December 11, 2015
    • Expiration Date: December 12, 2015
    • Contacts:

      Richard Mazurchuk, Ph.D.; Phone 240-276-7126; Email: mazurchukrv@mail.nih.gov

      Imaging related: Keyvan Farahani, Ph.D.; Phone: 240-276-5921; Email: farahank@mail.nih.gov

    This Funding Opportunity Announcement (FOA) invites research project (R01) applications that combine imaging and biomarkers. The overall objective of this FOA is to facilitate collaborative imaging and biomarker research to improve cancer screening, early cancer detection and diagnosis by integrating multi modality imaging strategies and multiplexed biomarker methodologies.